ACTUATE THERAPEUTICS, INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
ACTU$0.31-4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Item 6. | Exhibits |
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth below.
| Exhibit No. | Description |
| 10.1 | Securities Purchase Agreement, dated March 27, 2025, by and between Actuate Therapeutics, Inc. and B. Riley Principal Capital II, LLC (incorporated by reference from our Current Report on Form 8-K as filed on March 28, 2025) |
| 10.2 | Registration Rights Agreement, dated March 27, 2025, by and between Actuate Therapeutics, Inc. and B. Riley Principal Capital II, LLC (incorporated by reference from our Current Report on Form 8-K as filed on March 28, 2025) |
| 10.3*+ | Tenth Amendment to Employment Agreement by and between Daniel Schmitt and the Registrant dated March 11, 2025 |
| 10.4*+ | First Amendment to Employment Agreement by and between Andrew P. Mazar, Ph.D. and the Registrant dated March 11, 2025 |
| 10.5*+ | First Amendment to Employment Agreement by and between Paul Lytle and the Registrant dated March 11, 2025 |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended |
| 31.2* | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended |
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS* | XBRL Instance Document |
| 101.SCH* | XBRL Schema Document |
| 101.CAL* | XBRL Calculation Linkbase Document |
| 101.DEF* | XBRL Definition Linkbase Document |
| 101.LAB* | XBRL Label Linkbase Document |
| 101.PRE* | XBRL Presentation Linkbase Document |
| * | Filed herewith. |
|---|---|
| + | Indicates management contract or compensatory plan. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.